Status | Study |
Recruiting |
Study Name: MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2015-11-28 Interventions: Drug: Methotrexate 1g/m2/d IV |
Active, not recruiting |
Study Name: Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma Condition: Nasal Type Extranodal NK/T-Cell Lymphoma Date: 2015-11-22 Interventions: Drug: Pegaspargase Drug: Methotrexate |
Active, not recruiting |
Study Name: Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Condition: Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Date: 2015-09-11 Interventions: Other: chemotherapy followed by radiotherapy |
Recruiting |
Study Name: VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) Condition: Extranodal NK-T-Cell Lymphoma Date: 2015-09-06 Interventions: Drug: Etoposide Subjects will |
Terminated |
Study Name: P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens Condition: Lymphoma, Extranodal NK-T-Cell Date: 2015-08-24 Interventions: Drug: gemcitabine gemcitabine |
Completed |
Study Name: International Extranodal NK/T-cell Lymphoma Project Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2015-03-06 |
Recruiting |
Study Name: Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage Condition: Lymphoma, Extranodal NK-T-Cell Date: 2015-02-04 Interventions: Drug: Gemcitabine gemcitabine |
Completed |
Study Name: Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma Condition: Stage I/II Extranodal NK/T-cell Lymphoma Date: 2014-10-23 Interventions: Radiation: Intensity-modulated radiation therapy |
Recruiting |
Study Name: PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma Condition: Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Date: 2014-03-11 Interventions: Drug: pegaspargase pegaspargas |
Recruiting |
Study Name: Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL Condition: Lymphoma, Extranodal NK-T-Cell Date: 2014-03-02 Interventions: Drug: GELOX gemcitabine ᦂ |